Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment.

Harvey PD, Sacchetti E, Galluzzo A, Romeo F, Gorini B, Bilder RM, Loebel AD.

Schizophr Res. 2008 Oct;105(1-3):138-43. Epub 2008 Feb 20.

PMID:
18077136
2.

Augmentation of clozapine with ziprasidone in refractory schizophrenia: a double-blind, placebo-controlled study.

Muscatello MR, Pandolfo G, Micò U, Lamberti Castronuovo E, Abenavoli E, Scimeca G, Spina E, Zoccali R, Bruno A.

J Clin Psychopharmacol. 2014 Feb;34(1):129-33. doi: 10.1097/JCP.0000000000000042.

PMID:
24145221
3.

Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study.

Sacchetti E, Galluzzo A, Valsecchi P, Romeo F, Gorini B, Warrington L; INITIATE Study Group.

Schizophr Res. 2009 May;110(1-3):80-9. doi: 10.1016/j.schres.2009.02.017. Epub 2009 Mar 9.

PMID:
19269791
4.

Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study.

Sacchetti E, Galluzzo A, Valsecchi P, Romeo F, Gorini B, Warrington L; MOZART Study Group.

Schizophr Res. 2009 Aug;113(1):112-21. Erratum in: Schizophr Res. 2010 Aug;121(1-3)281. multiple investigator names added.

PMID:
19606529
5.

Ziprasidone and cognition: the evolving story.

Harvey PD.

J Clin Psychiatry. 2003;64 Suppl 19:33-9.

6.
7.

Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone.

Harvey PD, Ogasa M, Cucchiaro J, Loebel A, Keefe RS.

Schizophr Res. 2011 Apr;127(1-3):188-94. doi: 10.1016/j.schres.2011.01.004. Epub 2011 Jan 31.

PMID:
21277745
9.

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, Hsiao JK, Lieberman JA; CATIE Investigators; Neurocognitive Working Group.

Arch Gen Psychiatry. 2007 Jun;64(6):633-47.

PMID:
17548746
10.

The effects of clozapine on cognitive functioning in schizophrenia.

McGurk SR.

J Clin Psychiatry. 1999;60 Suppl 12:24-9. Review.

11.

Combination of clozapine and ziprasidone in treatment-resistant schizophrenia: an open clinical study.

Ziegenbein M, Kropp S, Kuenzel HE.

Clin Neuropharmacol. 2005 Sep-Oct;28(5):220-4.

PMID:
16239761
12.

Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia.

van Veelen NM, Grootens KP, Peuskens J, Sabbe BG, Salden ME, Verkes RJ, Kahn RS, Sitskoorn MM.

Schizophr Res. 2010 Jul;120(1-3):191-8. doi: 10.1016/j.schres.2010.04.011. Epub 2010 May 20.

PMID:
20493663
13.

Rosiglitazone and cognitive function in clozapine-treated patients with schizophrenia: a pilot study.

Yi Z, Fan X, Wang J, Liu D, Freudenreich O, Goff D, Henderson DC.

Psychiatry Res. 2012 Dec 30;200(2-3):79-82. doi: 10.1016/j.psychres.2012.05.020. Epub 2012 Jun 22.

PMID:
22727707
14.

Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.

Zink M, Kuwilsky A, Krumm B, Dressing H.

J Psychopharmacol. 2009 May;23(3):305-14. doi: 10.1177/0269881108089593. Epub 2008 Jun 18.

PMID:
18562423
15.

Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study.

Sumiyoshi T, Park S, Jayathilake K, Roy A, Ertugrul A, Meltzer HY.

Schizophr Res. 2007 Sep;95(1-3):158-68. Epub 2007 Jul 12.

PMID:
17628435
16.

Reduction of functional disability with atypical antipsychotic treatment: a randomized long term comparison of ziprasidone and haloperidol.

Harvey PD, Pappadopulos E, Lombardo I, Kremer CM.

Schizophr Res. 2009 Nov;115(1):24-9. doi: 10.1016/j.schres.2009.01.004. Epub 2009 Feb 3.

PMID:
19189878
17.
18.

A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.

Akdede BB, Anil Yağcioğlu AE, Alptekin K, Turgut TI, Tümüklü M, Yazici MK, Jayathilake K, Tunca Z, Göğüş A, Meltzer HY.

J Clin Psychiatry. 2006 Dec;67(12):1912-9.

PMID:
17194269
19.

Combination of ziprasidone and clozapine in treatment-resistant schizophrenia.

Zink M, Mase E, Dressing H.

Hum Psychopharmacol. 2004 Jun;19(4):271-3.

PMID:
15181656
20.

Ziprasidone augmentation of clozapine in 11 patients.

Kaye NS.

J Clin Psychiatry. 2003 Feb;64(2):215-6. No abstract available.

PMID:
12633133

Supplemental Content

Support Center